RBC Life Sciences, Inc. (RBCL) Research
Founded in 1988 and headquartered in Irving, Texas, RBC Life Sciences, Inc. is a global company engaged in the creation, marketing, and distribution of health-focused products, including nutritional supplements and personal care items. Its operations extend across North America, Southeast Asia, and Australia. The company operates through two main divisions. The Nutritional Products segment offers a wide array of dietary supplements, encompassing herbs, vitamins, and minerals, alongside natural skincare, haircare, and body care products. These are distributed through a network of independent sales representatives and license agreements. Notable offerings in this category include Stem-Kine for general dietary support; the antioxidant formulas Microhydrin and Microhydrin Plus; VitAloe, which combines several research-backed ingredients; OliViva, an antioxidant beverage aimed at bolstering immune and cardiovascular health; Organic Spirulina, a highly nutritious and easily digestible algae; and NeuroBright, designed to enhance brain function, energy, and mental sharpness. Other products within this segment include Colo-Vada Plus, a colon cleansing program; HydraCel, which improves drinking water quality; 24 Seven, a daily multivitamin/mineral supplement; Immune 360, formulated to support the immune system; and Aloe Gelee, a soothing and moisturizing gel. The Medical Products segment, known by the MPM Medical brand, specializes in advanced wound care solutions. This division produces treatments for various types of wounds, such as pressure ulcers, leg ulcers, cuts, burns, and abrasions. Its product line features cleansers, dressings, hydrogels, collagen, calcium alginates, moisture barriers, and antimicrobial agents, as well as a hydrogel wound dressing containing Lidocaine. Furthermore, this segment offers specialized products to minimize skin and tissue damage resulting from radiation exposure and to alleviate pain and itching caused by radiation reactions or specific cancer medications. These medical supplies are supplied to hospitals, nursing homes, clinics, and pharmacies via established medical/surgical supply dealers and pharmaceutical distributors.
Market snapshot
- Symbol
- RBCL
- Price
- $0.00
- Day change
- 0.00%
- Market cap
- $1.5K
- P/E ratio
- -0.00x
- 52-week range
- 0.0001-0.0007
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
Peer companies
Recent insider activity
- TYSINGER CYNTHIA L — trade (1800 shares) on 2012-12-11
Open RBC Life Sciences, Inc. (RBCL) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.